Stockscreener 앱 받기
4.18
5.53%
-0.25
전일 마감가:
$4.43
열려 있는:
$4.4
하루 거래량:
37,142
Relative Volume:
0.17
시가총액:
$193.72M
수익:
-
순이익/손실:
-
주가수익비율:
-2.1128
EPS:
-1.9784
순현금흐름:
-
1주 성능:
-22.36%
1개월 성능:
+29.97%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$4.13
$4.505
1주일 범위
$4.13
$5.80
52주 변동 폭
$2.34
$8.79
Anteris Technologies Global Corp Stock (AVR) Company Profile
명칭
Anteris Technologies Global Corp
전화
651-493-0606
주소
860 BLUE GENTIAN ROAD, EAGAN
AVR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
4.16 | 193.72M | 0 | 0 | 0 | -1.9784 |
|
ISRG
Intuitive Surgical Inc
|
534.30 | 184.23B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
169.22 | 48.46B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
98.11 | 47.15B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
240.97 | 35.24B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.09 | 16.39B | 3.90B | 392.30M | 288.10M | 1.95 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 개시 | Lake Street | Buy |
| 2025-01-07 | 개시 | Barclays | Overweight |
| 2025-01-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 개시 | TD Cowen | Buy |
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
Anteris Technologies Files Amendment to Annual Report - TipRanks
Anteris Technologies Announces Cessation of Certain Securities - TipRanks
Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street - The Globe and Mail
ASX Runners of the Week: Redstone Resources, Anteris & Jindalee Lithium - businessnews.com.au
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target - Investing.com
Anteris Technologies Announces Cessation of Securities - TipRanks
Anteris Technologies Announces New Securities Quotation - TipRanks
NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World
Anteris Technologies Reports March 2025 CDI Adjustments - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV By Investing.com - Investing.com Canada
Anteris reports over 100 patients treated with new heart valve By Investing.com - Investing.com South Africa
Anteris Technologies Hits Milestone with DurAVR® Heart Valve Treatment - Zenopa
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire
Anteris reports over 100 patients treated with new heart valve - Investing.com
Anteris Technologies announces 100 patients treated with DurAVR THV - TipRanks
Anteris Technologies Achieves Key Milestone in Cardiac Care - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV - Investing.com
Anteris Technologies Achieves Milestone with DurAVR® Heart Valve - TipRanks
Anteris Technologies marks clinical milestone with more than 100 patients treated using flagship DurAVR® THV - Proactive financial news
ASX Health Stocks: Anteris plans for US IPO and listing on Nasdaq - MSN
Head to Head Survey: Anteris Technologies Global (NASDAQ:AVR) & United Health Products (OTCMKTS:UEEC) - Defense World
Anteris Technologies reports one-year patient outcomes for DurAVR THV - TipRanks
Anteris shares rise on positive valve trial results By Investing.com - Investing.com Canada
Anteris Reports One-Year Patient Outcomes for DurAVR® THV - The Manila Times
Anteris shares rise on positive valve trial results - Investing.com India
Anteris Technologies Unveils Positive DurAVR® Patient Outcomes - TipRanks
Anteris Technologies delivers strong one-year results for DurAVR® Transcatheter Heart Valve - Proactive financial news
Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World
Anteris Technologies Global (NASDAQ:AVR) Stock Price Down 6.2% – What’s Next? - Defense World
Anteris Technologies: Advancing Toward FDA Approval with Positive Buy Rating - TipRanks
Anteris Technologies reports annual financial results By Investing.com - Investing.com South Africa
Anteris Technologies reports annual financial results - Investing.com India
Anteris Technologies: A Trailblazing Year of Innovation and Expansion - Kondor EXP
The morning catch up: ASX to reverse losses despite war of words over tariffs - Proactive financial news
Anteris Reports 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Anteris Technologies: A Transformational Leap with Its Nasdaq Debut and Heart Valve Breakthroughs - Kondor EXP
Anteris Technologies 2024 financials strong following Nasdaq debut, with plans for heart valve pivotal trial this year - Proactive Investors USA
Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive Investors Australia
Anteris Technologies Reports 2024 Financial Results and Advances Heart Valve Innovations - TipRanks
Anteris Technologies Reports Increased Losses Amid Strategic Reorganization - TipRanks
Anteris Technologies Global Corp (AVR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Anteris Technologies Global Corp 주식 (AVR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Paterson Wayne | Chief Executive Officer |
Mar 05 '25 |
Option Exercise |
7.13 |
233,000 |
1,661,290 |
233,000 |
| Denaro Stephen | Director |
Mar 11 '25 |
Option Exercise |
7.13 |
16,500 |
117,645 |
23,722 |
0.56%
0.32%
자본화:
|
볼륨(24시간):